173 related articles for article (PubMed ID: 33704881)
1. Antithymocyte globulin induction therapy and myocardial complement deposition in pediatric heart transplantation.
Ghaleb S; Wittekind SG; Martinez H; Kasten J; Gao Z; Hengehold T; Chin C
Pediatr Transplant; 2021 Sep; 25(6):e13998. PubMed ID: 33704881
[TBL] [Abstract][Full Text] [Related]
2. Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.
Butts RJ; Dipchand AI; Sutcliffe D; Bano M; Dimas V; Morrow R; Das B; Kirk R
Pediatr Transplant; 2018 Jun; 22(4):e13190. PubMed ID: 29878688
[TBL] [Abstract][Full Text] [Related]
3. Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
Zang S; Zhang X; Niu J; Das BB
Clin Transplant; 2023 Jan; 37(1):e14836. PubMed ID: 36259556
[TBL] [Abstract][Full Text] [Related]
4. Antithymocyte globulin is associated with complement deposition in cardiac transplant biopsies.
Baldwin WM; Armstrong LP; Samaniego-Picota M; Rahimi S; Zachary AA; Kasper EK; Conte JV; Hruban RH; Rodriguez ER
Hum Immunol; 2004 Nov; 65(11):1273-80. PubMed ID: 15556677
[TBL] [Abstract][Full Text] [Related]
5. Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.
Xu Y; Galambos C; Reyes-Múgica M; Miller SA; Zeevi A; Webber SA; Feingold B
J Heart Lung Transplant; 2013 Jan; 32(1):92-7. PubMed ID: 23260709
[TBL] [Abstract][Full Text] [Related]
6. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications.
Nickeleit V; Zeiler M; Gudat F; Thiel G; Mihatsch MJ
J Am Soc Nephrol; 2002 Jan; 13(1):242-251. PubMed ID: 11752044
[TBL] [Abstract][Full Text] [Related]
7. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
8. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients.
Dedinská I; Graňák K; Vnučák M; Skálová P; Laca Ĺ; Krivuš J; Galajda P; Mokáň M
Transplant Proc; 2019 Dec; 51(10):3259-3264. PubMed ID: 31732198
[TBL] [Abstract][Full Text] [Related]
9. A Single-Center Experience of the Optimal Initial Immunosuppressive Strategy for Preventing Early Acute Cellular Rejection in Orthotopic Heart Transplantation Associated With Renal Dysfunction.
Mundisugih J; Fernando H; Bergin P; Hare J; Kaye D; Leet A; McGiffin D; Taylor AJ
Prog Transplant; 2019 Dec; 29(4):327-334. PubMed ID: 31476958
[TBL] [Abstract][Full Text] [Related]
10. Assessment of immunosuppression induction with basiliximab compared to antithymocyte-globulin in adult heart transplant patients.
Eberhardt TE; Kim DH; Nethersole S; Pearson GJ
Clin Transplant; 2024 Jun; 38(6):e15332. PubMed ID: 38804609
[TBL] [Abstract][Full Text] [Related]
11. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
Kim JM; Jang HR; Kwon CH; Huh WS; Kim GS; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2012 Jan; 44(1):167-70. PubMed ID: 22310606
[TBL] [Abstract][Full Text] [Related]
12. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of kidney allograft outcomes in steroid use versus steroid discontinuation after basiliximab and ATG induction: A UNOS database study.
Nissaisorakarn P; Patel H; Cardarelli F; Amtul A
Clin Nephrol; 2024 Jul; 102():39-50. PubMed ID: 38699983
[TBL] [Abstract][Full Text] [Related]
14. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
15. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
[TBL] [Abstract][Full Text] [Related]
16. Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function?
Frea S; Iacovino C; Botta M; De Filippi I; Mazzucco G; Pidello S; Biolè C; Bergerone S; Boffini M; Praticò Barbato L; Morello M; Rinaldi M; Gaita F
Clin Transplant; 2016 Oct; 30(10):1314-1323. PubMed ID: 27490635
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
18. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
[TBL] [Abstract][Full Text] [Related]
19. Induction immunosuppression strategies and long-term outcomes after heart transplantation.
Nozohoor S; Stehlik J; Lund LH; Ansari D; Andersson B; Nilsson J
Clin Transplant; 2020 Jul; 34(7):e13871. PubMed ID: 32271484
[TBL] [Abstract][Full Text] [Related]
20. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]